The effect of a single dose of mifepristone given midcycle on the pattern of menstrual bleeding

niversity of Edinburgh (UK)0 个研究点目标入组 400 人开始时间: 2003年5月22日最近更新: 2015年1月13日

适应症

试验速览

暂无简介。

•1. Female volunteer aged 18-40 years inclusive
•2. Prepared to use barrier methods for the duration of the study, already have an Intra-Uterine Device (IUD) in-situ, previously sterilised (subject or partner), or not requiring contraception
•3. Regular menstrual cycles of between 25 to 35 days with no greater than three days variation in the past three months
•4. Willing to provide written informed consent

•1. Those who have used any type of hormonal contraception within three months of starting the trial
•2. Clinically relevant abnormal findings during the physical/gynaecological examination
•3. Those who have breastfed in the past three months
•4. Current treatment with corticosteroids
•5. Treatment with an investigational drug within one month of inclusion
•6. Long term use of any prescription drugs for a significant medical condition
•7. Chronic alcoholism, drug abuse or any other condition associated with poor patient compliance
•8. Undiagnosed vaginal bleeding
•9. Other significant disease e.g. cardiovascular, renal or liver disease or malignancy, sufficient to interfere with the evaluation of the study

发起方

niversity of Edinburgh (UK)